Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats
- Autores
- Peña, Delfina; Pontillo, Carolina Andrea; García, María Alejandra; Cocca, Claudia Marcela; Alvarez, Laura; Chiappini, Florencia Ana; Bourguignon, Nadia; Frahm, Isabel Leonor; Bergoc, Rosa Maria; Kleiman de Pisarev, Diana; Randi, Andrea Silvana
- Año de publicación
- 2012
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Hexachlorobenzene (HCB) is an organochlorine pesticide that acts as an endocrine disruptor in humans and rodents. The development of breast cancer strongly depends on endocrine conditions modulated by environmental factors. We have demonstrated that HCB is a tumor co carcinogen in rats and an inducer of proliferation in MCF-7 cells, in an estrogen receptor (ER)-dependent manner, and of migration in MDA-MB-231 breast cancer cell line. In the present study, we examined HCB effect on c-Src/human epidermal growth factor receptor (HER1) and ER signaling pathways in mammary glands and in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats. Furthermore, we evaluated histopathological changes and serum hormone levels. Rats were separated into four groups: control, HCB (100 mg/kg b.w.), NMU (50 mg/kg b.w.) and NMU-HCB. Our data show that HCB increases c-Src and HER1 activation, c-Src/HER1 association, and Y699-STAT5b and ERK1/2 phosphorylation in mammary glands. HCB also enhances Y537-ER phosphorylation and ER/c-Src physical interaction. In tumors, HCB also induces c-Src and HER1 activation, c-Src/HER1 association, as well as T308-Akt and Y699-STAT5b phosphorylation. In addition, the pesticide increases ER protein content and decreases p-Y537-ER levels and ER/c-Src association in tumors. HCB increases serum 17-beta estradiol and prolactin contents and decreases progesterone, FSH and LH levels in rats without tumors, while the opposite effect was observed in rats with tumors. Taken together, our results indicate that HCB induces an estrogenic effect in mammary gland, increasing c-Src/HER1 and ER signaling pathways. HCB stimulates cSrc/HER1 pathway, but decreases ER activity in tumors, appearing to shift them towards a higher malignancy phenotype.
Fil: Peña, Delfina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Pontillo, Carolina Andrea. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: García, María Alejandra. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
Fil: Cocca, Claudia Marcela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
Fil: Alvarez, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
Fil: Chiappini, Florencia Ana. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
Fil: Bourguignon, Nadia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Frahm, Isabel Leonor. Sanatorio Mater Dei;
Fil: Bergoc, Rosa Maria. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Kleiman de Pisarev, Diana. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
Fil: Randi, Andrea Silvana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina - Materia
-
HEXACHLOROBENZENE
MAMMARY GLAND
TUMOR PROMOTION
ESTROGEN RECEPTOR
HER1
C-SRC - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/270934
Ver los metadatos del registro completo
id |
CONICETDig_3d4f27b82179b3b3aec8ac2385e4689a |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/270934 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated ratsPeña, DelfinaPontillo, Carolina AndreaGarcía, María AlejandraCocca, Claudia MarcelaAlvarez, LauraChiappini, Florencia AnaBourguignon, NadiaFrahm, Isabel LeonorBergoc, Rosa MariaKleiman de Pisarev, DianaRandi, Andrea SilvanaHEXACHLOROBENZENEMAMMARY GLANDTUMOR PROMOTIONESTROGEN RECEPTORHER1C-SRChttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Hexachlorobenzene (HCB) is an organochlorine pesticide that acts as an endocrine disruptor in humans and rodents. The development of breast cancer strongly depends on endocrine conditions modulated by environmental factors. We have demonstrated that HCB is a tumor co carcinogen in rats and an inducer of proliferation in MCF-7 cells, in an estrogen receptor (ER)-dependent manner, and of migration in MDA-MB-231 breast cancer cell line. In the present study, we examined HCB effect on c-Src/human epidermal growth factor receptor (HER1) and ER signaling pathways in mammary glands and in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats. Furthermore, we evaluated histopathological changes and serum hormone levels. Rats were separated into four groups: control, HCB (100 mg/kg b.w.), NMU (50 mg/kg b.w.) and NMU-HCB. Our data show that HCB increases c-Src and HER1 activation, c-Src/HER1 association, and Y699-STAT5b and ERK1/2 phosphorylation in mammary glands. HCB also enhances Y537-ER phosphorylation and ER/c-Src physical interaction. In tumors, HCB also induces c-Src and HER1 activation, c-Src/HER1 association, as well as T308-Akt and Y699-STAT5b phosphorylation. In addition, the pesticide increases ER protein content and decreases p-Y537-ER levels and ER/c-Src association in tumors. HCB increases serum 17-beta estradiol and prolactin contents and decreases progesterone, FSH and LH levels in rats without tumors, while the opposite effect was observed in rats with tumors. Taken together, our results indicate that HCB induces an estrogenic effect in mammary gland, increasing c-Src/HER1 and ER signaling pathways. HCB stimulates cSrc/HER1 pathway, but decreases ER activity in tumors, appearing to shift them towards a higher malignancy phenotype.Fil: Peña, Delfina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Pontillo, Carolina Andrea. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: García, María Alejandra. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; ArgentinaFil: Cocca, Claudia Marcela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; ArgentinaFil: Alvarez, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; ArgentinaFil: Chiappini, Florencia Ana. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; ArgentinaFil: Bourguignon, Nadia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Frahm, Isabel Leonor. Sanatorio Mater Dei;Fil: Bergoc, Rosa Maria. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Kleiman de Pisarev, Diana. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; ArgentinaFil: Randi, Andrea Silvana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; ArgentinaElsevier Ireland2012-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/270934Peña, Delfina; Pontillo, Carolina Andrea; García, María Alejandra; Cocca, Claudia Marcela; Alvarez, Laura; et al.; Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats; Elsevier Ireland; Toxicology; 12-2012; 68-770300-483XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S0300483X11005476info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tox.2011.12.012info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:40:38Zoai:ri.conicet.gov.ar:11336/270934instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:40:39.253CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
title |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
spellingShingle |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats Peña, Delfina HEXACHLOROBENZENE MAMMARY GLAND TUMOR PROMOTION ESTROGEN RECEPTOR HER1 C-SRC |
title_short |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
title_full |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
title_fullStr |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
title_full_unstemmed |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
title_sort |
Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats |
dc.creator.none.fl_str_mv |
Peña, Delfina Pontillo, Carolina Andrea García, María Alejandra Cocca, Claudia Marcela Alvarez, Laura Chiappini, Florencia Ana Bourguignon, Nadia Frahm, Isabel Leonor Bergoc, Rosa Maria Kleiman de Pisarev, Diana Randi, Andrea Silvana |
author |
Peña, Delfina |
author_facet |
Peña, Delfina Pontillo, Carolina Andrea García, María Alejandra Cocca, Claudia Marcela Alvarez, Laura Chiappini, Florencia Ana Bourguignon, Nadia Frahm, Isabel Leonor Bergoc, Rosa Maria Kleiman de Pisarev, Diana Randi, Andrea Silvana |
author_role |
author |
author2 |
Pontillo, Carolina Andrea García, María Alejandra Cocca, Claudia Marcela Alvarez, Laura Chiappini, Florencia Ana Bourguignon, Nadia Frahm, Isabel Leonor Bergoc, Rosa Maria Kleiman de Pisarev, Diana Randi, Andrea Silvana |
author2_role |
author author author author author author author author author author |
dc.subject.none.fl_str_mv |
HEXACHLOROBENZENE MAMMARY GLAND TUMOR PROMOTION ESTROGEN RECEPTOR HER1 C-SRC |
topic |
HEXACHLOROBENZENE MAMMARY GLAND TUMOR PROMOTION ESTROGEN RECEPTOR HER1 C-SRC |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Hexachlorobenzene (HCB) is an organochlorine pesticide that acts as an endocrine disruptor in humans and rodents. The development of breast cancer strongly depends on endocrine conditions modulated by environmental factors. We have demonstrated that HCB is a tumor co carcinogen in rats and an inducer of proliferation in MCF-7 cells, in an estrogen receptor (ER)-dependent manner, and of migration in MDA-MB-231 breast cancer cell line. In the present study, we examined HCB effect on c-Src/human epidermal growth factor receptor (HER1) and ER signaling pathways in mammary glands and in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats. Furthermore, we evaluated histopathological changes and serum hormone levels. Rats were separated into four groups: control, HCB (100 mg/kg b.w.), NMU (50 mg/kg b.w.) and NMU-HCB. Our data show that HCB increases c-Src and HER1 activation, c-Src/HER1 association, and Y699-STAT5b and ERK1/2 phosphorylation in mammary glands. HCB also enhances Y537-ER phosphorylation and ER/c-Src physical interaction. In tumors, HCB also induces c-Src and HER1 activation, c-Src/HER1 association, as well as T308-Akt and Y699-STAT5b phosphorylation. In addition, the pesticide increases ER protein content and decreases p-Y537-ER levels and ER/c-Src association in tumors. HCB increases serum 17-beta estradiol and prolactin contents and decreases progesterone, FSH and LH levels in rats without tumors, while the opposite effect was observed in rats with tumors. Taken together, our results indicate that HCB induces an estrogenic effect in mammary gland, increasing c-Src/HER1 and ER signaling pathways. HCB stimulates cSrc/HER1 pathway, but decreases ER activity in tumors, appearing to shift them towards a higher malignancy phenotype. Fil: Peña, Delfina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina Fil: Pontillo, Carolina Andrea. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina Fil: García, María Alejandra. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina Fil: Cocca, Claudia Marcela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina Fil: Alvarez, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina Fil: Chiappini, Florencia Ana. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina Fil: Bourguignon, Nadia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Frahm, Isabel Leonor. Sanatorio Mater Dei; Fil: Bergoc, Rosa Maria. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina Fil: Kleiman de Pisarev, Diana. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina Fil: Randi, Andrea Silvana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina |
description |
Hexachlorobenzene (HCB) is an organochlorine pesticide that acts as an endocrine disruptor in humans and rodents. The development of breast cancer strongly depends on endocrine conditions modulated by environmental factors. We have demonstrated that HCB is a tumor co carcinogen in rats and an inducer of proliferation in MCF-7 cells, in an estrogen receptor (ER)-dependent manner, and of migration in MDA-MB-231 breast cancer cell line. In the present study, we examined HCB effect on c-Src/human epidermal growth factor receptor (HER1) and ER signaling pathways in mammary glands and in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats. Furthermore, we evaluated histopathological changes and serum hormone levels. Rats were separated into four groups: control, HCB (100 mg/kg b.w.), NMU (50 mg/kg b.w.) and NMU-HCB. Our data show that HCB increases c-Src and HER1 activation, c-Src/HER1 association, and Y699-STAT5b and ERK1/2 phosphorylation in mammary glands. HCB also enhances Y537-ER phosphorylation and ER/c-Src physical interaction. In tumors, HCB also induces c-Src and HER1 activation, c-Src/HER1 association, as well as T308-Akt and Y699-STAT5b phosphorylation. In addition, the pesticide increases ER protein content and decreases p-Y537-ER levels and ER/c-Src association in tumors. HCB increases serum 17-beta estradiol and prolactin contents and decreases progesterone, FSH and LH levels in rats without tumors, while the opposite effect was observed in rats with tumors. Taken together, our results indicate that HCB induces an estrogenic effect in mammary gland, increasing c-Src/HER1 and ER signaling pathways. HCB stimulates cSrc/HER1 pathway, but decreases ER activity in tumors, appearing to shift them towards a higher malignancy phenotype. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/270934 Peña, Delfina; Pontillo, Carolina Andrea; García, María Alejandra; Cocca, Claudia Marcela; Alvarez, Laura; et al.; Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats; Elsevier Ireland; Toxicology; 12-2012; 68-77 0300-483X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/270934 |
identifier_str_mv |
Peña, Delfina; Pontillo, Carolina Andrea; García, María Alejandra; Cocca, Claudia Marcela; Alvarez, Laura; et al.; Alterations in c-Src/HER1 and Estrogen Receptor alpha signaling pathways in mammary gland and tumors of Hexachlorobenzene-treated rats; Elsevier Ireland; Toxicology; 12-2012; 68-77 0300-483X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S0300483X11005476 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tox.2011.12.012 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier Ireland |
publisher.none.fl_str_mv |
Elsevier Ireland |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613286786498560 |
score |
13.070432 |